Skip to contentP
Phathom Pharmaceuticals, Inc.
P
PHATPhathom Pharmaceuticals, Inc. Q3 2023 · 10-Q
Revenue$0.00$0.00no prior Q3 2022 on file Net Income-$43.24M-$43.24MN/M vs Q3 2022 EPS Diluted-$0.76-$0.76N/M vs Q3 2022 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Phathom Pharmaceuticals, Inc. · CIK 1783183 · Engraved from SEC EDGAR
Operating Cash Flowderived-$31,914,000N/M Free Cash Flowderived-$32,853,000N/M ended Sep 30, 2023 · filed Nov 9, 2023 · 40 d after period end